Skip to main content
. 2018 Oct 4;3(4):e0031. doi: 10.2106/JBJS.OA.18.00031

TABLE I.

Preoperative Patient Characteristics*

Characteristic “SA-Expecting” Group “No-SA-Expecting” Group P Value
Female sex (no. of patients) 348 (57.5%) of 605 252 (72.6%) of 347 0.001
Age (yr) 65.2 ± 9.2 (n = 605) 72.7 ± 8.2 (n = 347) <0.001
Age group (no. of patients) <0.001
 ≤60 yr 160 (26.4%) of 605 25 (7.2%) of 347
 61-65 yr 129 (21.3%) of 605 42 (12.1%) of 347
 66-70 yr 147 (24.3%) of 605 61 (17.6%) of 347
 71-75 yr 99 (16.4%) of 605 78 (22.5%) of 347
 ≥76 yr 70 (11.6%) of 605 141 (40.6%) of 347
BMI (kg/m2) 27.0 ± 4.3 (n = 594) 27.2 ± 4.4 (n = 334) 0.701
Living status (no. of patients) 0.698
 Alone or with children 152 (25.5%) of 597 80 (23.3%) of 344
 With partner, with or without children 443 (74.2%) of 597 264 (76.7%) of 344
 Other (e.g., nursing home) 2 (0.3%) of 597 0 (0.0%) of 344
HOOS§
 Activities of daily living 38.5 ± 18.8 (n = 573) 43.3 ± 21.4# (n = 316) 0.001
 Pain 36.2 ± 17.6 (n = 585) 41.9 ± 20.6# (n = 317) <0.001
 Quality of life 32.5 ± 10.3 (n = 596) 35.5 ± 11.1# (n = 341) <0.001
 Sport 17.7 ± 18.2 (n = 581) 19.3 ± 19.6 (n = 325) 0.212
 Symptoms 38.9 ± 18.0 (n = 584) 42.2 ± 19.6# (n = 314) 0.012
SF-12 MCS§ 55.3 ± 9.4 (n = 565) 54.6 ± 9.5 (n = 310) 0.347
SF-12 PCS§ 31.9 ± 9.5 (n = 565) 32.5 ± 9.8 (n = 310) 0.416
EQ-5D§ 0.59 ± 0.26 (n = 596) 0.63 ± 0.24# (n = 332) 0.018
EQ-5D VAS§ 66.4 ± 18.2 (n = 563) 67.1 ± 18.8 (n = 315) 0.594
Comorbidities (no. of patients)
 Musculoskeletal “yes” 239 (56.4%) of 424 134 (60.1%) of 223 0.363
 Non-musculoskeletal “yes” 351 (67.8%) of 518 211 (74.8%) of 282 0.037
*

SA = sexual activity, BMI = body mass index, HOOS = Hip disability and Osteoarthritis Outcome Score, SF-12 = Short Form-12 Survey, PCS = Physical Component Summary, MCS = Mental Component Summary, EQ-5D = EuroQoL-5 Dimensions (Dutch version), and VAS = visual analog score.

P values for nominal categorical variables calculated with the Pearson chi-square test; for ordinal categorical variables, with the Armitage trend test; and for continuous variables, with the independent t test.

The values are given as the mean and the standard deviation.

§

All scales ranged from 0 to 100 except the EQ-5D, which ranged from 0 to 1; lower scores indicated worse outcomes.

#

Clinical relevance was assessed with use of minimum clinically important differences (MCIDs) for the SF-12 (MCID = 4.5)35 EQ-5D (MCID = 0.074)31 and HOOS (MCID = 9.1 points)36. No MCIDs were found.